US Pharma MarketingTampa General kicks off legal fight over Lilly
Tampa General Hospital sued Eli Lilly over revoked 340B discounts, citing Florida unfair trade practices law. The hospital faces 25-50% higher drug costs, including 35.9% more for Mounjaro. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act…
Tampa General Hospital sued Eli Lilly for halting its 340B discounts, kicking off a broader fight over whether pharmaceutical companies can condition drug discounts on new claims data requirements.
In a lawsuit filed Thursday, Tampa ...
Source: Endpoints News